Generally, when estrogen-like compounds bind selectively to ERβ, they can function as tumor suppressors; therefore, estrogen-like compounds that bind to ERβ can alleviate menopausal symptoms without the side effects associated with menopausal therapies, such as breast cancer [32]. Here, ESR2 is linked to breast cancer.